Orthofix Medical (OFIX) Research & Development (2010 - 2026)
Orthofix Medical's (OFIX) quarterly Research & Development came in at $15.3 million in Q1 2026, down 22.49% YoY from $19.8 million in Q1 2025, and little changed on a QoQ basis from $15.4 million in Q4 2025.
Orthofix Medical (OFIX) Research & Development (2010 - 2026) Analysis & Trends
Orthofix Medical (OFIX) has 17 years of Research & Development data on file, last reported at $15.3 million in Q1 2026.
- Quarterly Research & Development fell 22.49% year-over-year to $15.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $61.4 million (down 16.93% YoY) and the FY2025 annual result came in at $65.8 million, down 10.59% from the prior year.
- Research & Development steadied at $15.3 million in Q1 2026, from $15.4 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $99.2 million in Q2 2023 to a low of -$207.8 million in Q4 2023.
- A 5-year average of $7.5 million and a median of $17.3 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development soared 695.0% — and 2024, when it sank 81.81%.
- Tracing OFIX's Research & Development over 5 years: stood at -$120.4 million in 2022, then sank by 72.52% to -$207.8 million in 2023, then soared by 109.05% to $18.8 million in 2024, then decreased by 18.26% to $15.4 million in 2025, then decreased by 0.34% to $15.3 million in 2026.
- The last three Research & Development figures came in at $15.3 million (Q1 2026), $15.4 million (Q4 2025), and $14.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Orthofix Medical | 420.51 Mn | 316.11 Mn | 149.71 Mn | 15.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.94 Mn |
| Mar 31, 2026 | 15.32 Mn |
| Dec 31, 2025 | 15.37 Mn |
| Sep 30, 2025 | 14.77 Mn |
| Jun 30, 2025 | 15.93 Mn |
| Mar 31, 2025 | 19.77 Mn |
| Dec 31, 2024 | 18.81 Mn |
| Sep 30, 2024 | 17.29 Mn |
| Jun 30, 2024 | 18.05 Mn |
| Mar 31, 2024 | 19.49 Mn |
| Dec 31, 2023 | -207.76 Mn |
| Sep 30, 2023 | 94.95 Mn |
| Jun 30, 2023 | 99.25 Mn |
| Mar 31, 2023 | 23.31 Mn |
| Dec 31, 2022 | -120.42 Mn |
| Sep 30, 2022 | 11.94 Mn |
| Jun 30, 2022 | 59.89 Mn |
| Mar 31, 2022 | 11.21 Mn |
| Dec 31, 2021 | -114.60 Mn |
| Sep 30, 2021 | 56.10 Mn |